May 31, 2000Sanofi Pharmaceutical Recalls
NeGram Suspension Manufactured by Bayer
York, NY (SafetyAlerts) - The Food
and Drug Administration (FDA) today reported that Sanofi Pharmaceutical is conducting a
recall of NeGram Suspension (Nalidixic Acid Oral Suspension, USP), 250 mg/5mL, in 1 pint
bottles (Manufactured by Bayer Corporation) - because of superpotency (at stability -
The product is a prescription
medication indicated for the treatment of urinary tract infections
FDA stated in its report that 1,200
units were distributed Nationwide and in Canada. The firm estimated that 60 units
remained on market at time of recall initiation.
This ongoing Class III recall
was initiated by the company, by letter dated April 20, 2000. This is the first
public notice issued by the FDA.
Questions concerning this recall may
be directed to the FDA at 1-888-INFO-FDA.
FDA Recall #d-388-0
Notice of this product warning was
sent via email to SafeMail
subscribers May 31, 2000.
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.